BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 17898154)

  • 1. Characterization of the UDP glucuronosyltransferase activity of human liver microsomes genotyped for the UGT1A1*28 polymorphism.
    Zhang D; Zhang D; Cui D; Gambardella J; Ma L; Barros A; Wang L; Fu Y; Rahematpura S; Nielsen J; Donegan M; Zhang H; Humphreys WG
    Drug Metab Dispos; 2007 Dec; 35(12):2270-80. PubMed ID: 17898154
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human liver UDP-glucuronosyltransferase isoforms involved in the glucuronidation of 7-ethyl-10-hydroxycamptothecin.
    Hanioka N; Ozawa S; Jinno H; Ando M; Saito Y; Sawada J
    Xenobiotica; 2001 Oct; 31(10):687-99. PubMed ID: 11695848
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Raloxifene glucuronidation in human intestine, kidney, and liver microsomes and in human liver microsomes genotyped for the UGT1A1*28 polymorphism.
    Trdan Lusin T; Trontelj J; Mrhar A
    Drug Metab Dispos; 2011 Dec; 39(12):2347-54. PubMed ID: 21937736
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glucuronidation of antiallergic drug, Tranilast: identification of human UDP-glucuronosyltransferase isoforms and effect of its phase I metabolite.
    Katoh M; Matsui T; Yokoi T
    Drug Metab Dispos; 2007 Apr; 35(4):583-9. PubMed ID: 17220234
    [TBL] [Abstract][Full Text] [Related]  

  • 5. UGT1A1*28 genotype affects the in-vitro glucuronidation of thyroxine in human livers.
    Yoder Graber AL; Ramírez J; Innocenti F; Ratain MJ
    Pharmacogenet Genomics; 2007 Aug; 17(8):619-27. PubMed ID: 17622938
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Limited influence of UGT1A1*28 and no effect of UGT2B7*2 polymorphisms on UGT1A1 or UGT2B7 activities and protein expression in human liver microsomes.
    Peterkin VC; Bauman JN; Goosen TC; Menning L; Man MZ; Paulauskis JD; Williams JA; Myrand SP
    Br J Clin Pharmacol; 2007 Oct; 64(4):458-68. PubMed ID: 17555467
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterizing the effects of common UDP glucuronosyltransferase (UGT) 1A6 and UGT1A1 polymorphisms on cis- and trans-resveratrol glucuronidation.
    Iwuchukwu OF; Ajetunmobi J; Ung D; Nagar S
    Drug Metab Dispos; 2009 Aug; 37(8):1726-32. PubMed ID: 19406951
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of mutations associated with Gilbert and Crigler-Najjar type II syndromes on the glucuronidation kinetics of bilirubin and other UDP-glucuronosyltransferase 1A substrates.
    Udomuksorn W; Elliot DJ; Lewis BC; Mackenzie PI; Yoovathaworn K; Miners JO
    Pharmacogenet Genomics; 2007 Dec; 17(12):1017-29. PubMed ID: 18004206
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential modulation of UDP-glucuronosyltransferase 1A1 (UGT1A1)-catalyzed estradiol-3-glucuronidation by the addition of UGT1A1 substrates and other compounds to human liver microsomes.
    Williams JA; Ring BJ; Cantrell VE; Campanale K; Jones DR; Hall SD; Wrighton SA
    Drug Metab Dispos; 2002 Nov; 30(11):1266-73. PubMed ID: 12386134
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Substrate-dependent modulation of UDP-glucuronosyltransferase 1A1 (UGT1A1) by propofol in recombinant human UGT1A1 and human liver microsomes.
    Mano Y; Usui T; Kamimura H
    Basic Clin Pharmacol Toxicol; 2007 Sep; 101(3):211-4. PubMed ID: 17697043
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acyl glucuronidation of fluoroquinolone antibiotics by the UDP-glucuronosyltransferase 1A subfamily in human liver microsomes.
    Tachibana M; Tanaka M; Masubuchi Y; Horie T
    Drug Metab Dispos; 2005 Jun; 33(6):803-11. PubMed ID: 15769885
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of 3'-azido-3'-deoxythymidine, morphine, and codeine as probe substrates for UDP-glucuronosyltransferase 2B7 (UGT2B7) in human liver microsomes: specificity and influence of the UGT2B7*2 polymorphism.
    Court MH; Krishnaswamy S; Hao Q; Duan SX; Patten CJ; Von Moltke LL; Greenblatt DJ
    Drug Metab Dispos; 2003 Sep; 31(9):1125-33. PubMed ID: 12920168
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of N-glucuronidation of 4-(5-pyridin-4-yl-1H-[1,2,4]triazol-3-yl) pyridine-2-carbonitrile (FYX-051): a new xanthine oxidoreductase inhibitor.
    Omura K; Nakazawa T; Sato T; Iwanaga T; Nagata O
    Drug Metab Dispos; 2007 Dec; 35(12):2143-8. PubMed ID: 17761779
    [TBL] [Abstract][Full Text] [Related]  

  • 14. UDP-glucuronosyltransferase 1A1 is the principal enzyme responsible for etoposide glucuronidation in human liver and intestinal microsomes: structural characterization of phenolic and alcoholic glucuronides of etoposide and estimation of enzyme kinetics.
    Wen Z; Tallman MN; Ali SY; Smith PC
    Drug Metab Dispos; 2007 Mar; 35(3):371-80. PubMed ID: 17151191
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interindividual variability in acetaminophen glucuronidation by human liver microsomes: identification of relevant acetaminophen UDP-glucuronosyltransferase isoforms.
    Court MH; Duan SX; von Moltke LL; Greenblatt DJ; Patten CJ; Miners JO; Mackenzie PI
    J Pharmacol Exp Ther; 2001 Dec; 299(3):998-1006. PubMed ID: 11714888
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epirubicin glucuronidation is catalyzed by human UDP-glucuronosyltransferase 2B7.
    Innocenti F; Iyer L; Ramírez J; Green MD; Ratain MJ
    Drug Metab Dispos; 2001 May; 29(5):686-92. PubMed ID: 11302935
    [TBL] [Abstract][Full Text] [Related]  

  • 17. UDP-glucuronosyltransferase 1A1 is the principal enzyme responsible for puerarin metabolism in human liver microsomes.
    Luo CF; Cai B; Hou N; Yuan M; Liu SM; Ji H; Xiong LG; Xiong W; Luo JD; Chen MS
    Arch Toxicol; 2012 Nov; 86(11):1681-90. PubMed ID: 22648071
    [TBL] [Abstract][Full Text] [Related]  

  • 18. UGT1A1*28 polymorphism influences glucuronidation of bazedoxifene.
    Lušin TT; Mrhar A; Trontelj J
    Pharmazie; 2015 Feb; 70(2):94-6. PubMed ID: 25997248
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of bisphenol A glucuronidation according to UGT1A1*28 polymorphism by a new LC-MS/MS assay.
    Trdan Lušin T; Roškar R; Mrhar A
    Toxicology; 2012 Feb; 292(1):33-41. PubMed ID: 22154984
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolism of the c-Fos/activator protein-1 inhibitor T-5224 by multiple human UDP-glucuronosyltransferase isoforms.
    Uchihashi S; Fukumoto H; Onoda M; Hayakawa H; Ikushiro S; Sakaki T
    Drug Metab Dispos; 2011 May; 39(5):803-13. PubMed ID: 21346002
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.